These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 841671)

  • 21. Transmission of viral hepatitis, type B, by plasma derivatives.
    Barker LF; Hoofnagle JH
    Dev Biol Stand; 1974; 27():178-88. PubMed ID: 4142771
    [No Abstract]   [Full Text] [Related]  

  • 22. Factor IX concentrates .
    Ménaché D
    Thromb Diath Haemorrh; 1975 Jun; 33(3):600-5. PubMed ID: 1154314
    [No Abstract]   [Full Text] [Related]  

  • 23. Monoclonal IgM radioimmunoassay for hepatitis B surface antigen: high binding activity in serum that is unreactive with conventional antibodies.
    Wands JR; Bruns RR; Carlson RI; Ware A; Menitove JE; Isselbacher KJ
    Proc Natl Acad Sci U S A; 1982 Feb; 79(4):1277-81. PubMed ID: 6951173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemagglutination inhibiton in capillary tubes--a simple and reliable test for HBsAg.
    Milner LV; Ellis JL; Viljoen MH; Marimuthu T; Godefroy J
    Transfusion; 1977; 17(3):233-7. PubMed ID: 867463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute viral hepatitis in adults. Comparison of the radioimmunoassay and counterimmunoelectrophoresis methods of detecting HbsAg.
    Wenzel RP; Teates CD; Galapon Q; Barczak R; Ling CM; Overby LR
    JAMA; 1975 Apr; 232(4):366-8. PubMed ID: 47402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of post-transfusion infection with the hepatitis delta virus. A multicenter study.
    Rosina F; Saracco G; Rizzetto M
    N Engl J Med; 1985 Jun; 312(23):1488-91. PubMed ID: 3990749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factor IX antigen by radioimmunoassay. Abnormal factor IX protein in patients on warfarin therapy and with hemophilia B.
    Thompson AR
    J Clin Invest; 1977 May; 59(5):900-10. PubMed ID: 856873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Detection of HBsAg and the related antibody (HBsAb) with the radioimmunological method. Behavior of the HBeAg-HBcAb system in HBsAg-positive patients].
    Ortona L; Pizzigallo E; Federico G; Camilli G
    Arch Sci Med (Torino); 1979; 136(4):509-22. PubMed ID: 550751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell-mediated immune reactivity to hepatitis B surface antigen in liver diseases.
    de Moura MC; Vernace SJ; Paronetto F
    Gastroenterology; 1975 Aug; 69(2):310-17. PubMed ID: 1080122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood transfusion: merits of component therapy. II. The clinical use of plasma and plasma components.
    Buchholz DH
    J Pediatr; 1974 Feb; 84(2):165-72. PubMed ID: 4589841
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of HBsAg detection methods from AABB-CAP survey data.
    Polesky HF; Taswell HF
    Am J Clin Pathol; 1975 Jun; 63(6 SUPPL):1002-6. PubMed ID: 807099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of tests for HBeAg and anti-HBe in HBsAg positive blood donors.
    Dow BC; Macvarish I; Barr A; Crawford RJ; Mitchell R
    J Clin Pathol; 1980 Nov; 33(11):1106-9. PubMed ID: 7440758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlations between the detection of e antigen or antibody and electron microscopic pattern of hepatitis B surface antigen (HBsAg) associated particles in the serum of HBsAg carriers.
    Trepo C; Bird RG; Zuckerman AJ
    J Clin Pathol; 1977 Mar; 30(3):216-20. PubMed ID: 403201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Non-activated and activated prothrombin complex concentrates, Proplex and Feiba, in the treatment of a hemophilia B patient with high titer inhibitor against factor IX].
    Niiya K; Hirose S; Taguchi H; Miyoshi I
    Rinsho Ketsueki; 1985 Jun; 26(6):980-4. PubMed ID: 3877825
    [No Abstract]   [Full Text] [Related]  

  • 35. Cellular and humoral immunity to hepatitis-B surface antigen in active chronic hepatitis.
    Lee WM; Reed WD; Mitchell CG; Galbraith RM; Eddleston AL; Zuckerman AJ; Williams R
    Br Med J; 1975 Mar; 1(5960):705-8. PubMed ID: 1125673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B antigen and systemic lupus erythematosus. False positive complement fixation due to anti-antibodies.
    Celada A; Nydegger UE; Lambert PH; Miescher PA
    Klin Wochenschr; 1976 Apr; 54(7):303-7. PubMed ID: 1083449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tests for Dane particles in serum concentrates of HBsAg positive hemodialysis patients.
    Hess G; Arnold W; Koesters W; Meyer zum Büschenfelde KH
    Clin Nephrol; 1979 Jan; 11(1):18-22. PubMed ID: 428150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Radioimmunological determination of HBeAg/anti-HBe in HBsAg-positive liver diseases and in "healthy" HBsAg carriers].
    Arnold W; Hess G; Dormeyer HH; Gahl G; Hoffmann HG; Knolle J; Schönborn H
    Z Gastroenterol; 1979 Oct; 17(10):704-12. PubMed ID: 118595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transfusion-transmitted virus is not present in factor IX concentrates commonly used to treat haemophilia B.
    Oza VM; Jabbar AA; Hakobyan N; Kazarian T; Valentino LA
    Haemophilia; 2004 Nov; 10(6):732-4. PubMed ID: 15569169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization and experimental use of a monospecific antiserum to factor IX.
    Pechet L; Tiarks CY; Chang CH; Sudhindra RR; Lipworth L
    Thromb Haemost; 1979 Feb; 40(3):455-64. PubMed ID: 106483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.